MaxCyte Inc (NASDAQ:MXCT) shares, rose in value on Wednesday, June 18, with the stock price down by -1.86% to the previous day’s close as strong demand from buyers drove the stock to $2.11.
Actively observing the price movement in the last trading, the stock closed the session at $2.15, falling within a range of $2.1 and $2.18. The value of beta (5-year monthly) was 1.041. Referring to stock’s 52-week performance, its high was $5.20, and the low was $2.10. On the whole, MXCT has fluctuated by -7.46% over the past month.
With the market capitalization of MaxCyte Inc currently standing at about $224.33 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MXCT’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of MXCT currently trading nearly -6.16% and -13.37% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.51, while the 7-day volatility ratio is showing 2.58% which for the 30-day chart, stands at 4.28%. Furthermore, MaxCyte Inc (MXCT)’s average true range (ATR) is 0.13.
A comparison of MaxCyte Inc (MXCT) with its peers suggests the former has fared considerably weaker in the market. MXCT showed an intraday change of -1.86% in last session, and over the past year, it shrunk by -56.94%%.
Data on historical trading for MaxCyte Inc (NASDAQ:MXCT) indicates that the trading volumes over the past 10 days have averaged 0.8 and over the past 3 months, they’ve averaged 880.47K. According to company’s latest data on outstanding shares, there are 106.31 million shares outstanding.
Nearly 7.88% of MaxCyte Inc’s shares belong to company insiders and institutional investors own 74.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.54 million shares as on 2025-05-30, resulting in a short ratio of 2.89. According to the data, the short interest in MaxCyte Inc (MXCT) stood at 335.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 3.54 million. The stock has fallen by -49.28% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MXCT stock heading into the next quarter.
